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p38/RK is essential for stress-induced nuclear responses:
JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient
Catherine A. Hazzalin*, Eva Cano*, Ana Cuenda†, Michael J. Barratt*, 
Philip Cohen† and Louis C. Mahadevan*
The ERK, JNK/SAPK and p38/RK MAP kinase subtypes
(reviewed in [1]) are differentially activated in
mammalian cells by various stimuli, which elicit
induction of immediate–early (IE) genes, such as c-fos
and c-jun (reviewed in [1–3]), as well as
phosphorylation of histone H3 [4] and HMG-14 [5].
Anisomycin and UV radiation have been suggested to
induce c-fos and c-jun transcription via JNK/SAPK-
mediated phosphorylation of TCF (ternary complex
factor), for c-fos induction [6–8], and c-Jun and/or ATF-2
for c-jun induction [9–13]. We report here that
anisomycin and ultraviolet radiation (UV) activate MAP
kinase kinase-6 (MKK6) [14,15], p38/RK [16–18] and
MAPKAP kinase-2 (MAPKAP K-2) [17–19]. By using the
p38/RK inhibitor SB 203580 [20,21], we show that
activation of p38/RK and/or its downstream effectors
are essential for anisomycin- and UV-stimulated c-
fos/c-jun induction and histone H3/HMG-14
phosphorylation, whereas JNK/SAPK activation and
phosphorylation of c-Jun and ATF-2 are insufficient for
these responses.
Addresses: *Nuclear Signalling Laboratory, Developmental Biology
Research Centre, The Randall Institute, King’s College London, 26–29
Drury Lane, London WC2B 5RL, UK. †MRC Protein Phosphorylation
Unit, Department of Biochemistry, Medical Sciences Institute,
University of Dundee, DD1 4HN, UK.
Correspondence to: Louis C. Mahadevan. 
E-mail: udbr061@kcl.ac.uk
Received: 3 May 1996
Revised: 12 June 1996
Accepted: 12 June 1996
Current Biology 1996, Vol 6 No 8:1028–1031
© Current Biology Ltd ISSN 0960-9822
Results and discussion
The activation of kinase cascades in C3H 10T½ murine
fibroblasts by various stimuli has been described previ-
ously [19,22,23]. We recently showed that anisomycin and
UV radiation strongly activate MAPKAP K-2 in C3H 10T½
cells [19], implying that these stimuli must also activate the
upstream kinase p38/RK (reviewed in [1]). To analyze this
process in greater detail, lysates from cells stimulated with
EGF (epidermal growth factor), anisomycin or UV radia-
tion were subjected to Mono S chromatography, and frac-
tions assayed for upstream activators of p38/RK. In parallel,
these lysates were assayed for p38/RK and MAPKAP K-2
activities (data not shown), which correlated closely with
the activity of the upstream activator of p38/RK (Fig. 1a).
The major activator of p38/RK (peak 1) coeluted with
MKK6 (Fig. 1a; [14,15]). This activity was immunoprecipi-
tated specifically by anti-MKK6 antibodies but not by anti-
MKK3 antibodies (Fig. 1b). The minor activator of p38/RK
(peak II), seen only in response to anisomycin, was
immunoprecipitated by anti-MKK3 antibodies but not by
anti-MKK6 antibodies (Fig. 1b). Neither the major, nor the
minor, p38/RK activator was immunoprecipitated by anti-
MKK4 antibodies (Fig. 1b). MKK6 is also the major
p38/RK activator in KB cells and THP-1 monocytes but
not in PC12 cells [15]. An important role for MKK6 in acti-
vating p38/RK is evident from the fact that, although
MKK3 does activate co-transfected over-expressed
p38/RK, it only activates the endogenous enzyme very
weakly, whereas transfected MKK6 activates endogenous
p38/RK efficiently [14].
Time-course analyses showed that EGF activated MKK6
(Fig. 1c), p38/RK (data not shown) and MAPKAP K-2
(data not shown; see [19,23]) weakly and very transiently;
activity returned to basal levels within 15 minutes. In con-
trast, anisomycin and UV radiation produced strong activa-
tion at all three levels of this cascade, and activity
remained high at 60 minutes (Fig. 1c, and data not
shown). Similar assays showed that okadaic acid activated
this cascade more gradually, but to high levels, whereas
TPA (12-O-tetradecanoylphorbol 13-acetate) did not acti-
vate this pathway at all (data not shown). These observa-
tions are exactly as expected from our previous analyses of
two kinases, p45 and p55 [23], recently identified as
MAPKAP K-2 [19].
The pyridinyl imidazole compound SB 203580 binds
specifically to p38/RK and inhibits its activity, thereby
preventing activation of its downstream kinase MAPKAP
K-2 [20,21]. We found that SB 203580 inhibited p38/RK
isolated from C3H 10T½ cells by Mono Q chromatogra-
phy with an in vitro IC50 value (0.6 mM) identical to that
required to inhibit p38/RK from other mammalian cells
(data not shown). Consistent with this finding, SB 203580
strongly inhibited MAPKAP K-2 activation in C3H 10T½
cells in response to anisomycin (90 % inhibition) or UV
radiation (80 % inhibition; data not shown). In contrast,
activation of its upstream activator MKK6 was not inhib-
ited and, if anything, was slightly augmented (data not
shown); this may reflect ablation of negative-feedback
influences normally originating from downstream kinases.
To confirm its specificity, we also showed that SB 203580
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did not affect ERK activation in response to EGF or TPA
(data not shown), or JNK/SAPK activation in response to
EGF, anisomycin or UV radiation (data not shown; see
also Fig. 3a).
The time-course and relative strengths of induction of
c-fos and c-jun in response to EGF, anisomycin and UV
radiation in C3H 10T½ cells have been described [22,23].
SB 203580 strongly inhibited the induction of c-fos and
c-jun by anisomycin and UV radiation (Fig. 2a). The
extent of inhibition for both genes (80–90 %) was similar
to the inhibition of p38/RK under these conditions (see
above). By reprobing these blots, we also found that SB
203580 blocked anisomycin- and UV-stimulated induction
of junB by 80–90 %, but was less effective (~65 % inhibi-
tion) at blocking junD induction (C.A.H. and L.C.M,
unpublished observations). However, SB 203580 did not
inhibit the induction of c-fos and c-jun in response to EGF
(Fig. 2a); in fact, we consistently observed augmented
c-fos and c-jun mRNA levels under these conditions. This
enhancement was not attributable to increased stability of
these transcripts (data not shown), but could conceivably
have resulted from increased activation of other MKK6-
triggered routes to these genes (see above). Similarly, the
Figure 2
Effect of SB 203580 on the induction of c-fos
and c-jun by EGF, anisomycin and UV
radiation. (a) Northern blot analysis of c-fos
and c-jun expression. C3H 10T½ cells
incubated in the presence (+) or absence (–)
of 20 mM SB 203580 for 15 min, were then
stimulated with EGF (50 ng ml–1 for 30 min);
anisomycin (sAn; 25 ng ml–1 for 45 min); UV
radiation (UV; 200 J m–2 for 45 min), as
indicated. Lane 1, control (C; unstimulated);
lane 8, SB 203580 (20 mM, 60 min). The
optimal times for each stimulus, and the
relative strength of induction of c-fos and c-jun
at these time points were determined by time-
course analysis over 60 min, as described
[22]. Procedures for C3H 10T½ cell culture,
RNA extraction, northern blotting and the
probes used have been described ([22] and
references therein). (b) Dose-dependent
inhibition of anisomycin stimulated induction of
c-fos and c-jun by SB 203580. Lane 1, control
(unstimulated); lanes 2–7, cells stimulated with
anisomycin (sAn; 25 ng ml–1) for 45 min. SB
203580 at the indicated concentrations was
added 15 min before stimulation with
anisomycin.
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Figure 1
Activation of p38/RK activators by anisomycin,
UV radiation and EGF in C3H 10T½ cells. (a)
Mono S chromatography of p38/RK activators
from C3H 10T½ cell extracts. Quiescent cells
(open circles) or cells stimulated with
anisomycin (50 ng ml–1, 30 min; closed
circles), UV radiation (400 J m–2, 30 min; open
triangles) or EGF (50 ng ml–1, 5 min; closed
triangles) were lysed, and aliquots (0.3 mg
protein) chromatographed in a Pharmacia
SMART system using 5 × 0.16 cm Mono S
columns, as described [15,17,25]. The
p38/RK activator kinase assay was identical to
that described previously [25]. One unit of
activity was the amount that increased the
activity of MalE–XMpk2 by one unit per minute
[26]. Subinhibitory concentrations of
anisomycin (below those required to inhibit
protein synthesis [27]) were used here to
eliminate considerations of translational arrest;
inhibitory concentrations also produced very
strong activation of this cascade. (b) The major
p38/RK activator seen in (a) was
immunoprecipitated by anti-MKK6 antibodies.
Aliquots of column fractions from peaks I and II
in (a) were immunoprecipitated, as described
previously, with anti-MKK4 [26], anti-MKK6
[15], or anti-MKK3 antibodies [15]. The graph
shows the p38/RK activity remaining in the
supernatant after immunoprecipitation in the
presence (+) or absence (–) of the appropriate
competing peptide immunogen, relative to
control incubations (100 %) where antibody
was omitted. The p38/RK activator activity was
assayed as described above. (c) Time-course
analysis of MKK6 activation by anisomycin, UV
radiation and EGF. Quiescent cells were
stimulated for the times indicated with
anisomycin (50 ng ml–1; closed circles), UV
radiation (400 J m–2; open triangles) or EGF
(50 ng ml–1; closed triangles), and lysates were
subjected to Mono S chromatography; MKK6
activity was quantitated as described above.
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induction of c-fos and c-jun by TPA was unaffected or
slightly augmented in the presence of this inhibitor (data
not shown). Dose-dependence studies showed that
SB 203580 effectively ablated c-fos and c-jun induction at
low micromolar concentrations (Fig. 2b) similar to those
required to inhibit p38/RK and its activation of
MAPKAP K-2. Thus, induction of c-fos and c-jun by ani-
somycin and UV radiation, but not by EGF or TPA, was
substantially inhibited under conditions where the
p38/RK MAP kinase cascade was inhibited by SB 203580.
We then asked if the phosphorylation of transcription
factors that control IE genes was affected by the inhibitor.
For these studies, we focused on the transcription factors
c-Jun and ATF-2, which are differentially phosphorylatable
by JNK/SAPKs and p38/RK, and implicated in c-jun induc-
tion [9–12]. Our results showed conclusively that ani-
somycin- and UV-stimulated c-Jun and ATF-2
phosphorylation were unaffected by SB 203580 (Fig. 3a), an
observation which agrees with the finding that under these
conditions JNK/SAPKs remain strongly active. Treatment
with anisomycin elicited stoichiometric and prolonged
c-Jun phosphorylation (data not shown), and some loss of
immunoreactivity, possibly resulting from degradation (Fig.
3a). These experiments were repeated in human MRC-5
cells with identical results (data not shown). Furthermore,
we found, as expected, that EGF-stimulated phosphoryla-
tion of c-Jun and ATF-2, which is much weaker and more
transient, was unaffected by SB 203580 (data not shown).
Note that in this study we have avoided using transfected
epitope-tagged or over-expressed proteins, which have the
potential to produce misleading results.
Finally, we investigated the effects of SB 203580 on the
nucleosomal response, the phosphorylation of histone H3
[4] and HMG-14 [5], which is thus far the only nuclear
event that we have found to be invariably associated with
IE gene induction [22]. As shown in Figure 3b, the effect
of SB 203580 on the nucleosomal response closely paral-
leled its effects on IE gene induction: SB 203580 did not
affect histone H3 or HMG-14 phosphorylation elicited by
EGF, but completely ablated phosphorylation produced
by either subinhibitory or inhibitory concentrations of ani-
somycin. Thus, in anisomycin-stimulated SB 203580-
treated cells, JNK/SAPKs remained active and c-Jun and
ATF-2 remained highly phosphorylated (Fig. 3a), whereas
c-fos and c-jun induction (Fig. 2a,b) and the nucleosomal
events (Fig. 3b) were strongly inhibited, emphasizing
further the tight correlation between IE gene induction
and the nucleosomal response.
These results, in accord with recent and emerging evi-
dence [20,21,24], confirm the high specificity of
SB 203580 as an inhibitor of p38/RK and prove that it does
not interfere non-specifically with IE gene induction, the
phosphorylation of transcription factors c-Jun and ATF-2,
or with the nucleosomal response. Furthermore, they
show that p38/RK is clearly essential for nuclear responses
induced by anisomycin and UV radiation, but not by EGF.
An important corollary here is that, although ATF-2 is a
substrate for p38/RK in vitro, its phosphorylation in these
experiments cannot be attributed to p38/RK. Under con-
ditions where ERKs are inactive, JNK/SAPKs have been
proposed to mediate c-fos activation by phosphorylating
TCFs [6–8], although this has not been verified in intact
Figure 3
Effect of SB 203580 on the phosphorylation
of nuclear proteins. (a) SB 203580 has no
effect on anisomycin- or UV-stimulated
phosphorylation of c-Jun or ATF-2. C3H
10T½ cells were incubated in the presence
(+) or absence (–) of SB 203580, and either
unstimulated (lanes 1 and 2) or stimulated
with anisomycin at inhibitory (An; lanes 3 and
4) or subinhibitory (sAn; lanes 7 and 8)
concentrations, or with UV radiation (lanes 5
and 6), as indicated. The cells were then lysed
and nuclear extracts [28] were run on
SDS–polyacrylamide gels, and western
blotting was carried out using anti-c-Jun or
anti-ATF-2 antibodies, as indicated. The anti-
c-Jun antibody (Affiniti) was used at 1:1000
dilution, and the anti-ATF-2 antibody (Santa-
Cruz) was used at 1:500 dilution. After
washing [22], blots were incubated with
sheep second antibody coupled to
horseradish peroxidase (1:10,000 in TBST)
for 1 h, washed as before and visualized using
the Renaissance detection system (NEN).
Migration of phosphorylated c-Jun and ATF-2
is retarded on these gels. (b) SB 203580
inhibits anisomycin-stimulated but not EGF-
stimulated histone H3 and HMG-14
phosphorylation. Confluent quiescent C3H
10T½ cells were labelled with 32P-phosphate
as described [4,5], incubated in the presence
(+) or absence (–) of 20 mM SB 203580 for
15 min, and then stimulated with EGF
(50 ng ml–1), subinhibitory anisomycin (sAn;
50 ng ml–1) or inhibitory anisomycin (An;
10 mg ml–1), as indicated. Lanes 1 and 2:
control (C; unstimulated) cells. After
sequential extraction, proteins from the
chromatin-enriched fraction were extracted,
and resolved on acid–urea gels [4,5] in which
histone H3 resolves into multiple forms
according to its state of modification,
principally acetylation [5].
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untransfected cells. Our data suggest that, even if this
occurs in vivo, it is insufficient for c-fos activation; events
mediated by p38/RK or its downstream kinases are also
required. The recent observations that selective activation
of p38/RK induces a reporter construct driven by the c-fos
serum-response element, and that p38/RK phosphorylates
Elk-1 in vitro [14], may explain the p38/RK-dependence
of c-fos induction seen here. It is unclear whether the
stress-induced nuclear events require p38/RK itself or its
downstream kinases. p38/RK is clearly capable of phos-
phorylating transcription factors, such as CHOP, in intact
cells — an event blocked by SB 203580 [24]. Alterna-
tively, or in addition, the nuclear response may require not
p38/RK but its downstream effector MAPKAP K-2. For
instance, MAPKAP K-2 mediates phosphorylation and
activation of CREB (cyclic AMP response element-
binding protein) in response to cytokines and cellular
stress ([25]; J. Rouse and P.C., unpublished observations),
an event which may participate in activating c-fos through
upstream CRE sites (reviewed in [2]).
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